中文 | English
Return
Total: 440 , 1/44
Show Home Prev Next End page: GO
Author:(Xu-Qin SHI)

1.Clinicopathologic analysis of 17 cases of malacoplakia

Yinhua SHI ; Na WEI ; Jingjie FU ; Mengke QIN ; Jingjing XU

Chinese Journal of Clinical and Experimental Pathology 2025;41(5):591-595

2.Epidemiological dynamics and spatiotemporal diffusion trend of brucellosis in China from 2010 to 2024

Yunfei ZHANG ; Xinlou LI ; Qiang XU ; Di MU ; Yue SHI ; Xi CHEN ; Haijian ZHOU ; Tian QIN ; Biao KAN ; Canjun ZHENG ; Liqun FANG

Chinese Journal of Preventive Medicine 2025;59(6):884-891

3.Effects of different acupuncture and moxibustion methods on synovial hypoxia and fibrosis in knee osteoarthritis model rats

Lingling QIN ; Xiaoqin ZHANG ; Qi DONG ; Mengting SHI ; Pingju XUE ; Haijiao XING ; Jing XU

Journal of Acupuncture and Tuina Science 2025;23(5):394-402

4.Expert consensus on non-surgical treatment for acute lateral ankle sprain (version 2025)

Hui CHE ; Wenge DING ; Shiming FENG ; Xueping GU ; Qinwei GUO ; Jianchao GUI ; Yinghui HUA ; Yuefeng HAO ; Qinglin HAN ; Bo HU ; Xiaojun LIANG ; Guoping LI ; Yunxia LI ; Qi LI ; Yanlin LI ; Xin MA ; Jun MA ; Xudong MIAO ; Jianzhong QIN ; Xiaodong QIN ; Xu SUN ; Kefu SUN ; Weidong SONG ; Dai SHI ; Zhongmin SHI ; Youlun TAO ; Xu WANG ; Youhua WANG ; Liheng WANG ; Anli WANG ; Aiguo WANG ; Weidong WU ; Yajun XU ; Weidong XU ; Renjie XU ; Yongsheng XU ; Tengbo YU ; Lianqi YAN ; Xiaodong YUAN ; Yuan ZHU ; Mingzhu ZHANG ; Hongtao ZHANG ; Xintao ZHANG ; Xiaofei ZHENG

Chinese Journal of Trauma 2025;41(6):517-529

5.Bendamustine combined with anti-CD20 monoclonal antibody in the first-line treatment of older patients with indolent B-cell non-Hodgkin lymphoma: a multicenter retrospective study

Shuchao QIN ; Yi MIAO ; Zhaoliang ZHANG ; Jie ZHANG ; Yuye SHI ; Yuqing MIAO ; Weiying GU ; Weicheng ZHENG ; Zhuxia JIA ; Guoqiang LIN ; Haiwen NI ; Xiaohong XU ; Min XU ; Xiaoyan XIE ; Ling WANG ; Yun ZHUANG ; Wei ZHANG ; Ping LIU ; Jianyong LI ; Wenyu SHI

Chinese Journal of Hematology 2025;46(9):820-826

6.Development of an evaluation indicator system for access to cancer screening services: a Delphi study

Xin WANG ; Ayan MAO ; Xinyi ZHOU ; Pei DONG ; Yanjie LI ; Senyao CAI ; Yujie WU ; Huiyao HUANG ; Guoxiang LIU ; Wanghong XU ; Jiangmei QIN ; Wanqing CHEN ; Jufang SHI

Chinese Journal of Epidemiology 2025;46(2):307-315

7.Relationship among occupational stress, work-related rumination, and sleep quality in emergency medical dispatchers in some areas of China

Xiaoying SHI ; Qing ZHANG ; Zhongyuan YAN ; Qin ZHANG ; Dan XU

Journal of Environmental and Occupational Medicine 2025;42(8):932-938

8.Expert consensus on prognostic evaluation of cochlear implantation in hereditary hearing loss.

Xinyu SHI ; Xianbao CAO ; Renjie CHAI ; Suijun CHEN ; Juan FENG ; Ningyu FENG ; Xia GAO ; Lulu GUO ; Yuhe LIU ; Ling LU ; Lingyun MEI ; Xiaoyun QIAN ; Dongdong REN ; Haibo SHI ; Duoduo TAO ; Qin WANG ; Zhaoyan WANG ; Shuo WANG ; Wei WANG ; Ming XIA ; Hao XIONG ; Baicheng XU ; Kai XU ; Lei XU ; Hua YANG ; Jun YANG ; Pingli YANG ; Wei YUAN ; Dingjun ZHA ; Chunming ZHANG ; Hongzheng ZHANG ; Juan ZHANG ; Tianhong ZHANG ; Wenqi ZUO ; Wenyan LI ; Yongyi YUAN ; Jie ZHANG ; Yu ZHAO ; Fang ZHENG ; Yu SUN

Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(9):798-808

9.Discovery of a novel AhR-CYP1A1 axis activator for mitigating inflammatory diseases using an in situ functional imaging assay.

Feng ZHANG ; Bei ZHAO ; Yufan FAN ; Lanhui QIN ; Jinhui SHI ; Lin CHEN ; Leizhi XU ; Xudong JIN ; Mengru SUN ; Hongping DENG ; Hairong ZENG ; Zhangping XIAO ; Xin YANG ; Guangbo GE

Acta Pharmaceutica Sinica B 2025;15(1):508-525

10.LncRNA EUDAL shapes tumor cell response to hypoxia-induced constitutive EGFR activation and promotes chemoresistance in oral cancer.

Shengkai CHEN ; Zhenlin DAI ; Jianbo SHI ; Mengyu RUI ; Zhiyuan ZHANG ; Qin XU

International Journal of Oral Science 2025;17(1):64-64

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 440 , 1/44 Show Home Prev Next End page: GO